Cite
MLA Citation
N. G. Daver et al.. “S132: TOLERABILITY AND EFFICACY OF THE FIRST-IN-CLASS ANTI-CD47 ANTIBODY MAGROLIMAB COMBINED WITH AZACITIDINE IN FRONTLINE PATIENTS WITH TP53-MUTATED ACUTE MYELOID LEUKEMIA: PHASE 1B RESULTS.” HemaSphere, vol. 6, n.d., pp. 33–34. http://access.bl.uk/ark:/81055/vdc_100158013693.0x00001c